ATE552847T1 - Hiv-impfstoffzusammensetzung - Google Patents

Hiv-impfstoffzusammensetzung

Info

Publication number
ATE552847T1
ATE552847T1 AT06705249T AT06705249T ATE552847T1 AT E552847 T1 ATE552847 T1 AT E552847T1 AT 06705249 T AT06705249 T AT 06705249T AT 06705249 T AT06705249 T AT 06705249T AT E552847 T1 ATE552847 T1 AT E552847T1
Authority
AT
Austria
Prior art keywords
hiv
vaccine
vaccine composition
composition
mixtures
Prior art date
Application number
AT06705249T
Other languages
English (en)
Inventor
Jose Torres
David Anderson
Francisco Diaz-Mitoma
Original Assignee
Variation Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Variation Biotechnologies Inc filed Critical Variation Biotechnologies Inc
Application granted granted Critical
Publication of ATE552847T1 publication Critical patent/ATE552847T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT06705249T 2005-03-01 2006-02-28 Hiv-impfstoffzusammensetzung ATE552847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65690805P 2005-03-01 2005-03-01
PCT/CA2006/000295 WO2006092046A1 (en) 2005-03-01 2006-02-28 Hiv vaccine composition

Publications (1)

Publication Number Publication Date
ATE552847T1 true ATE552847T1 (de) 2012-04-15

Family

ID=36585937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06705249T ATE552847T1 (de) 2005-03-01 2006-02-28 Hiv-impfstoffzusammensetzung

Country Status (5)

Country Link
US (1) US8029797B2 (de)
EP (1) EP1861121B1 (de)
AT (1) ATE552847T1 (de)
CA (1) CA2540279C (de)
WO (1) WO2006092046A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
BR112012000826B1 (pt) 2009-07-06 2022-07-26 Variation Biotechnologies Inc Método para a preparação de vesículas
CA2803282C (en) 2009-07-06 2018-05-01 David E. Anderson Methods for preparing vesicles and formulations produced therefrom
WO2012006367A2 (en) 2010-07-06 2012-01-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
EP2422618A1 (de) * 2010-08-27 2012-02-29 Technologie Integrale Ltd. Tiermodell zur Beurteilung der Wirksamkeit eines HIV-Impfstoffs
CA2862864C (en) 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2890084C (en) 2011-11-18 2021-05-04 Maura Ellen Campbell Synthetic derivatives of mpl and uses thereof
EP2802353A4 (de) 2012-01-12 2015-12-02 Variation Biotechnologies Inc Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN104244984B (zh) 2012-01-27 2020-03-31 变异生物技术公司 用于治疗剂的方法和组合物
US10383927B2 (en) 2015-01-09 2019-08-20 Primex Clinical Laboratories, Inc. Variable epitope library compositions and methods of therapeutic and prophylactic use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
EP1225907A4 (de) 1999-10-05 2005-06-22 Epimmune Inc Induktion zellulärer immunantworten gegen humanes immundefiziens virus-1 (hiv-1) mittels peptid- und nukleinsäureverbindungen
US7180195B2 (en) 2003-12-17 2007-02-20 Intel Corporation Method and apparatus for improved power routing

Also Published As

Publication number Publication date
EP1861121B1 (de) 2012-04-11
WO2006092046A1 (en) 2006-09-08
CA2540279A1 (en) 2006-06-14
CA2540279C (en) 2009-10-20
EP1861121A1 (de) 2007-12-05
EP1861121A4 (de) 2009-01-21
US8029797B2 (en) 2011-10-04
US20090117141A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
NZ585674A (en) Vaccination with multiple clades of h5 influenza a virus
WO2006020071A3 (en) Vaccines against aids comprising cmv/r-nucleic acid constructs
WO2007024941A3 (en) Polyvalent vaccine
WO2011106100A3 (en) Method of inducing the production of protective anti-hiv-1 antibodies
ATE552847T1 (de) Hiv-impfstoffzusammensetzung
WO2010114628A3 (en) Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
MX2021006342A (es) Mutantes de virus de influenza y usos para los mismos.
EP4241785A3 (de) Influenzavirus-impfstoffe und verwendungen davon
WO2007022151A3 (en) Immunization of avians by administration of non-replicating vectored vaccines
WO2010019262A3 (en) Polyvalent vaccine
NZ599059A (en) Pcsk9 vaccine
UA110024C2 (uk) Вакцинний вектор і спосіб посилення імунної відповіді
WO2008068631A3 (en) Vaccines including antigen from four strains of influenza virus
WO2015142671A3 (en) Influenza virus vectors and uses therefor
WO2013006688A3 (en) N-terminal deleted gp120 immunogens
NZ628449A (en) Neisseria meningitidis compositions and methods thereof
AR093712A1 (es) Composicion inmunogena, vacuna, uso y procedimiento de prevencion o tratamiento
EA201591213A1 (ru) Вакцины против вируса гепатита b
WO2008005929A3 (en) Recombinant hiv-1 gp120 immunogen with three different v3 loops from viruses of different clades
WO2006095330A3 (en) Methods and immunogenic cell preparations for treating antigen-associated diseases
NZ597458A (en) Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
MX2014014682A (es) Glicoproteina 120 (gp120) estabilizada.
WO2006138567A3 (en) Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
WO2012047267A3 (en) Polyvalent immunogen
WO2006138568A3 (en) Multivalent entrain-and-amplify immunotherapeutics for carcinoma